TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 54,807 | 46,726 | 43,878 |
Financial expenses | 518 | 391 | 288 |
Earnings before taxes | 1,517 | 2,734 | 2,341 |
EBITDA | 4,013 | 4,773 | 3,695 |
Total assets | 49,151 | 44,559 | 42,826 |
Current assets | 25,091 | 19,277 | 16,836 |
Current liabilities | 17,409 | 9,218 | 7,204 |
Equity capital | 29,713 | 22,256 | 20,509 |
- share capital | 899 | 978 | 996 |
Employees (average) | 312 | 278 | 256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 60.5% | 49.9% | 47.9% |
Turnover per employee | 176 | 168 | 171 |
Profit as a percentage of turnover | 2.8% | 5.9% | 5.3% |
Return on assets (ROA) | 4.1% | 7.0% | 6.1% |
Current ratio | 144.1% | 209.1% | 233.7% |
Return on equity (ROE) | 5.1% | 12.3% | 11.4% |
Change turnover | 11,866 | 3,661 | 9,208 |
Change turnover % | 28% | 9% | 27% |
Chg. No. of employees | 34 | 22 | 55 |
Chg. No. of employees % | 12% | 9% | 27% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.